ECG Findings in Methamphetamine Use

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-65
SponsorElazığ Mental Health and Diseases Hospital

About this trial

This prospective cohort study aims to examine and compare electrocardiogram (ECG) parameters in subjects diagnosed with Methamphetamine Use Disorder (MUD) and Methamphetamine-Induced Psychotic Disorder (MP) during inpatient psychiatric treatment. ECG findings at hospital admission and during remission prior to discharge will be evaluated and compared between groups. The study also aims to determine whether methamphetamine-induced psychosis is associated with greater ECG abnormalities and increased cardiac risk compared to methamphetamine use without psychosis.

Eligibility criteria

Qualifiers

Diagnosis of MUD according to DSM-5-TR

Medication-free for at least one month prior to admission

Age ≥ 18 years and <65 years

Provided informed consent

Disqualifiers

Diabetes mellitus

Chronic kidney disease

Rheumatoid arthritis

Systemic lupus erythematosus

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

240 Participants
are grouped into 3 trial groups